# Lifemel Honey to Reduce Leucopenia During Chemotherapy

> **NCT00243165** · PHASE2 · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BEHAVIORAL:** Lifemel honey intake every day

## Key facts

- **NCT ID:** NCT00243165
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243165, "Lifemel Honey to Reduce Leucopenia During Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00243165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*